Sebastian Lighvani, MD
Allergy/ Immunology · New York, NYNPI 1407879885
Payments from drug & device makers
Across 751 payments — averaging $124.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$63K
- Optinose US, Inc.$7K
- Regeneron Healthcare Solutions, Inc.$6K
- Sanofi$5K
- Genentech, Inc.$3K
- GSK$2K
- plus $8K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 86 | $62,856 |
| Optinose US, Inc. | 59 | $6,838 |
| Regeneron Healthcare Solutions, Inc. | 27 | $5,745 |
| Sanofi | 59 | $5,193 |
| Genentech, Inc. | 6 | $2,871 |
| GSK | 179 | $1,997 |
| Alk-abello, Inc | 16 | $1,768 |
| CSL Behring | 45 | $972 |
| Novartis | 39 | $672 |
| Kaleo, Inc. | 30 | $631 |
| Sanofi-aventis U.S. LLC | 10 | $588 |
| Pfizer | 28 | $581 |
| Amgen | 16 | $330 |
| AbbVie | 14 | $289 |
| Teva Pharmaceuticals USA, Inc. | 29 | $229 |
| Genentech USA, Inc. | 17 | $161 |
| Hikma Pharmaceuticals USA | 7 | $146 |
| ARS Pharmaceuticals Operations, Inc. | 22 | $141 |
| Dermavant Sciences, Inc. | 1 | $140 |
| Octapharma USA, Inc. | 6 | $131 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $129 |
| Pharming Healthcare, Inc. | 7 | $120 |
| Biocryst US Sales Co., LLC | 7 | $112 |
| Grifols USA, LLC | 7 | $110 |
| Smith+Nephew | 1 | $107 |
| GC Biopharma USA, Inc. | 4 | $72 |
| Incyte Corporation | 3 | $61 |
| Ionis Pharmaceuticals, Inc. | 3 | $58 |
| Boehringer Ingelheim | 3 | $54 |
| Blueprint Medicines Corporation | 2 | $39 |
| Covis Pharma GmbH | 2 | $36 |
| Organon | 2 | $34 |
| Galderma Laboratories, L.p. | 2 | $32 |
| Merck | 1 | $27 |
| Arcutis Biotherapeutics, Inc. | 1 | $25 |
| Shire North American Group Inc | 1 | $16 |
| LEO Pharma Inc. | 1 | $14 |
How this compares
Too few allergy/ immunology providers in New Yorkto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy/ immunology in New York
- Joel SelterSuffern$84K
- Jessica SternRochester$5K
- David MenchellFresh Meadows$3K
- Michael LandorFlushing$2K
- Louis GuidaWest Bay Shore$795
- Craig OsleebMount Kisco$0
- Andrew ChangBrooklyn$0
- Avi DeenerWhite Plains$0
- Laura MechanicWhite Plains$0
- Gary WeinstockGreat Neck$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.